Improved Alzheimer Disease Diagnosis With a Machine Learning Approach and Neuroimaging: Case Study Development
JMIRx Med · 21.04.2025 · 6 · e60866-e60866
DOI: 10.2196/60866 ↗Kurz gefasst
Fachartikel in der Zeitschrift JMIRx Med, online erschienen am 21.04.2025. Verfasst von Lilia Lazli. Beteiligte Einrichtung: Department of Computer and Software Engineering, Polytechnique Montréal, University of Montreal, 2500 Chem de Polytechnique, Montreal, QC, H3T 1J4, C…. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Alzheimer disease (AD) is a severe neurological brain disorder. While not curable, earlier detection can help improve symptoms substantially. Machine learning (ML) models are popular and well suited for medical image processing tasks such as computer-aided diagnosis. These techniques can improve the process for an accurate diagnosis of AD.
Objective
In this paper, a complete computer-aided diagnosis system for the diagnosis of AD has been presented. We investigate the performance of some of the most used ML techniques for AD detection and classification using neuroimages from the Open Access Series of Imaging Studies (OASIS) and Alzheimer’s Disease Neuroimaging Initiative (ADNI) datasets.
Methods
The system uses artificial neural networks (ANNs) and support vector machines (SVMs) as classifiers, and dimensionality reduction techniques as feature extractors. To retrieve features from the neuroimages, we used principal component analysis (PCA), linear discriminant analysis, and t-distributed stochastic neighbor embedding. These features are fed into feedforward neural networks (FFNNs) and SVM-based ML classifiers. Furthermore, we applied the vision transformer (ViT)–based ANNs in conjunction with data augmentation to distinguish patients with AD from healthy controls.
Results
Experiments were performed on magnetic resonance imaging and positron emission tomography scans. The OASIS dataset included a total of 300 patients, while the ADNI dataset included 231 patients. For OASIS, 90 (30%) patients were healthy and 210 (70%) were severely impaired by AD. Likewise for the ADNI database, a total of 149 (64.5%) patients with AD were detected and 82 (35.5%) patients were used as healthy controls. An important difference was established between healthy patients and patients with AD ( P =.02). We examined the effectiveness of the three feature extractors and classifiers using 5-fold cross-validation and confusion matrix–based standard classification metrics, namely, accuracy, sensitivity, specificity, precision, F 1 -score, and area under the receiver operating characteristic curve (AUROC). Compared with the state-of-the-art performing methods, the success rate was satisfactory for all the created ML models, but SVM and FFNN performed best with the PCA extractor, while the ViT classifier performed best with more data. The data augmentation/ViT approach worked better overall, achieving accuracies of 93.2% (sensitivity=87.2, specificity=90.5, precision=87.6, F 1 -score=88.7, and AUROC=92) for OASIS and 90.4% (sensitivity=85.4, specificity=88.6, precision=86.9, F 1 -score=88, and AUROC=90) for ADNI.
Conclusions
Effective ML models using neuroimaging data could help physicians working on AD diagnosis and will assist them in prescribing timely treatment to patients with AD. Good results were obtained on the OASIS and ADNI datasets with all the proposed classifiers, namely, SVM, FFNN, and ViTs. However, the results show that the ViT model is much better at predicting AD than the other models when a sufficient amount of data are available to perform the training. This highlights that the data augmentation process could impact the overall performance of the ViT model.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Computer and Software Engineering, Polytechnique Montréal, University of Montreal, 2500 Chem de Polytechnique, Montreal, QC, H3T 1J4, Canada, 1(514) 340-5121 ext 3750.
Zitieren
APA
Lazli, L. (2025). Improved Alzheimer Disease Diagnosis With a Machine Learning Approach and Neuroimaging: Case Study Development. JMIRx Med, 6, e60866-e60866. https://doi.org/10.2196/60866
Vancouver
Lazli L. Improved Alzheimer Disease Diagnosis With a Machine Learning Approach and Neuroimaging: Case Study Development. JMIRx Med. 2025;6:e60866-e60866. doi:10.2196/60866
BibTeX
@article{Lazli2025,
author = {Lazli, Lilia},
title = {Improved Alzheimer Disease Diagnosis With a Machine Learning Approach and Neuroimaging: Case Study Development},
journal = {JMIRx Med},
year = {2025},
volume = {6},
pages = {e60866--e60866},
doi = {10.2196/60866}
}
EUVIMED